Gilead Sciences is now halfway through its 10-year pledge in the US southern states to tackle HIV through community grants, and looking back while also doubling down on new approaches to the still-growing problem.
Its Commitment to Partnership in Addressing HIV in Southern States (COMPASS) is now aiming for an…
Click here to view original post
